Telangana IT & industries minister Duddilla Sridhar Babu inaugurating the global life sciences and technology centre of US-based biopharmaceutical company Syneos Health in Hyderabad on Wednesday
Pointing out that Hyderabad already accounts for an estimated 20-23% of India’s healthcare-biotech global capability centres market, he said the city’s ecosystem spans APIs, bulk drugs, generics, CDMO, vaccines, research and discovery, along with a growing base of global healthcare and biotech GCCs, positioning Hyderabad as a global testbed for AI-enabled life sciences.
The company said the Hyderabad facility will function as a strategic growth hub rather than a traditional delivery centre, housing global leaders and multidisciplinary teams supporting drug development and commercialisation for customers worldwide. Inaugurating the facility, Sridhar Babu said Syneos’ entry means Hyderabad now hosts four of the world’s top five contract research organisations.